McKesson Corporation (MCK)

McKesson Financials Overview

Financials in millions USD. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	403,430	403,430	359,051	308,951	276,711	263,966
Revenue Growth	12.36%	12.36%	16.22%	11.65%	4.83%	10.80%
Gross Profit Gross Profit Growth	14,550	14,550	13,323	12,828	12,358	13,130
Operating Income Operating Income Growth	6,212	6,212	4,422	3,909	4,381	2,038
Net Income Net Income Growth	4,762	4,762	3,295	3,002	3,560	1,114
Earnings Per Share EPS Growth	38.38	38.38	25.72	22.39	25.03	7.23
EPS Growth	49.22%	49.22%	14.87%	-10.55%	246.20%	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
North American Pharmaceutical North American Pharmaceutical Growth	336,652	336,652	304,507	261,368	-	-
Oncology & Multispecialty Oncology & Multispecialty Growth	48,423	48,423	36,862	30,490	-	-
Prescription Technology Solutions Prescription Technology Solutions Growth	5,805	5,805	5,216	4,769	4,387	3,864
Medical Surgical Solutions Medical Surgical Solutions Growth	11,507	11,507	11,380	11,309	11,110	11,608
Other Segment Other Segment Growth	1,043	1,043	1,086	1,015	-	-
Revenue (Total) Revenue (Total) Growth	403,430	403,430	359,051	308,951	276,711	263,966

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	3,975	3,975	5,691	4,583	4,678	3,532
Total Debt Total Debt Growth	8,614	8,614	7,390	7,390	7,295	7,542
Net Cash (Debt) Net Cash Growth	-4,639	-4,639	-1,699	-2,807	-2,617	-4,010
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-37.38	-37.38	-13.26	-20.93	-18.40	-26.02

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	6,155	6,155	6,085	4,314	5,159	4,434
Capital Expenditures CapEx Growth	-436	-436	-537	-431	-390	-388
Free Cash Flow Free Cash Flow Growth	5,719	5,719	5,548	3,883	4,769	4,046
Free Cash Flow Growth	3.08%	3.08%	42.88%	-18.58%	17.87%	-1.10%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	3.61%	3.61%	3.71%	4.15%	4.47%	4.97%
Operating Margin	1.54%	1.54%	1.23%	1.27%	1.58%	0.77%
Pretax Margin	1.54%	1.54%	1.21%	1.23%	1.67%	0.73%
Profit Margin	1.26%	1.26%	0.97%	1.02%	1.35%	0.49%
FCF Margin	1.42%	1.42%	1.55%	1.26%	1.72%	1.53%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 26, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	3.280	3.170	2.750	2.400	2.090	1.830
Dividend Per Share Growth	15.25%	15.27%	14.58%	14.83%	14.21%	9.58%
Dividend Yield	0.39%	0.36%	0.40%	0.44%	0.58%	0.59%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 26, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	21.91	22.55	26.17	23.98	14.22	42.34
Forward PE	19.00	19.99	18.47	18.47	13.59	13.44
P/FCF Ratio	17.21	18.16	15.16	17.97	10.15	10.97
PS Ratio	0.24	0.26	0.23	0.23	0.17	0.17

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error